A valuable approach to understand how individual and population genetic differences can predispose to disease is to assess the impact of genetic variants on cellular functions (e.g., gene expression) of cell and tissue types related to pathological states. To understand the genetic basis of nonsyndromic cleft lip with or without cleft palate (NSCL/P) susceptibility, a complex and highly prevalent congenital malformation, we searched for genetic variants with a regulatory role in a disease-related tissue, the lip muscle (orbicularis oris muscle [OOM]), of affected individuals. From 46 OOM samples, which are frequently discarded during routine corrective surgeries on patients with orofacial clefts, we derived mesenchymal stem cells and correlated the individual genetic variants with gene expression from these cultured cells. Through this strategy, we detected significant cis-eQTLs (i.e., DNA variants affecting gene expression) and selected a few candidates to conduct an association study in a large Brazilian cohort (624 patients and 668 controls). This resulted in the discovery of a novel susceptibility locus for NSCL/P, rs1063588, the best eQTL for the MRPL53 gene, where evidence for association was mostly driven by the Native American ancestry component of our Brazilian sample. MRPL53 (2p13.1) encodes a 39S protein subunit of mitochondrial ribosomes and interacts with MYC, a transcription factor required for normal facial morphogenesis. Our study illustrates not only the importance of sampling admixed populations but also the relevance of measuring the functional effects of genetic variants over gene expression to dissect the complexity of disease phenotypes.
Introduction
Nonsyndromic cleft lip with or without cleft palate (NSCL/P) is a multifactorial complex disorder, and several genetic susceptibility loci as well as environmental risk factors have been identified (Dixon et al. 2011; Ludwig et al. 2012; Leslie et al. 2016) . As observed in the majority of complex disorders, NSCL/P genome-wide association studies (GWAS) have predominantly implicated noncoding genetic variants as influencing disease susceptibility (Hindorff et al. 2011; Maurano et al. 2012) . For example, the strongest association reported for NSCL/P lies in a gene desert at 8q24, recently implicated in MYC regulation (Uslu et al. 2014) . Furthermore, signals from GWAS are not always associated with the closest gene, as has been exemplified in NSCL/P (Leslie et al. 2012; Savastano et al. 2016) . In this context, an alternative approach to search for functional effects of genetic variants on a genome-wide basis, especially those influencing gene expression, involves identifying expression quantitative trait loci (eQTLs) in different cell or tissue types (Dimas et al. 2009; Dermitzakis 2012; Grundberg et al. 2012; Melé et al. 2015) and prioritizing these variants when conducting case-control association studies. cis-eQTLs, as opposed to trans-eQTLs, are conventionally defined as DNA variants within 1 Mb upstream or downstream to the transcription start site (TSS) of the target gene, a region that may include polymorphisms affecting intragenic and cis-regulatory consensus sequences, as well as trans-acting regulators close to the target gene (Cheung and Spielman 2009) .
NSCL/P arises as a consequence of developmental dysregulation of craniofacial structures originated from first and second embryonic pharyngeal arches during weeks 4 to 12 of pregnancy (Wilkie and Morriss-Kay 2001) . Orbicularis oris muscle (OOM), an accessible source of mesenchymal stem cells (Bueno et al. 2009 ), is often damaged in NSCL/P patients, and it may be primarily involved in the origin of the defect (Weinberg et al. 2008) . Therefore, genes expressed in OOM mesenchymal stem cells (OOMMSCs), which represent the least differentiated state of cells of this niche that can be studied, are more likely to be involved in the pathogenesis of NSCL/P.
In this work, we mapped cis-eQTLs in OOMMSCs from affected individuals by correlating genome-wide expression levels and genotypic data. We next tested some of these putative functional variants as candidates for NSCL/P susceptibility in an association study of a large case-control sample from Brazil.
Materials and Methods

Ethics Statement
Informed consent was obtained from patients, controls, or legal tutors, and the Biosciences Institute's Research Ethics Committee (University of São Paulo) approved this study. This study conformed to STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) guidelines for observational studies.
OOM Samples and Cell Culture Conditions
We obtained OOM samples from 42 NSCL/P-affected and 4 normal individuals who underwent reconstructive plastic surgery (Appendix Table 1 ) and further established OOMMSC Figure 1 . Analysis workflow. We describe the steps for orbicularis oris muscle mesenchymal stem cell (OOMMSC)-expression quantitative trait locus (eQTL) analysis in (A) and those related to the case-control association study in (B). Briefly, we first identified regulatory variants in OOMMSC (eQTLs) and then searched for association between a few of these variants (n = 36) and risk to cleft lip with or without cleft palate (NSCL/P). (A) The key elements involved in cis-eQTL discovery: 1-Mb window upstream and downstream to TSS, candidate single-nucleotide polymorphisms (SNPs) (triangles) within this interval, and gene expression measured by a probe. A typical eQTL is represented by distributions of gene expression values stratified according to SNP genotypes. (B) Venn diagram illustrates the overlap between case-control samples used in the disease association study and in the eQTL analysis.
primary cultures according to previously published protocols (Bueno et al. 2009 ) (Appendix Methods).
Gene Expression Quantification and Genotyping Microarrays
We measured transcript levels and genotyped 500,000 SNPs through microarrays (Affymetrix). Genotype calling, raw expression data normalization, and filtering steps are fully described in the Appendix Methods.
eQTL Mapping
QTLtools is a tool set implemented in C ++ for molecular QTL discovery and analysis, which measures the association between genotypes and expression with a linear regression model (Delaneau et al. 2017) . We used this tool to test on a large-scale basis the association between pairs of SNP genotypes and transcript expression levels (we tested 3,897,692 pairs), using age, sex, ancestry fractions, and case-control status as covariates. The rate of false positives due to multiple testing was controlled at 2 levels: first, through permutations and β distribution-adjusted P values, with QTLtools corrected for multiple SNPs tested per transcript. Second, through FDR estimations (Storey and Tibshirani 2003) using qvalue 1.36.0 (R software), we corrected for the multiple transcripts tested. We applied a 0.05 q value cutoff, based on the maximum number of discovered eQTLs (n = 12) with the minimum proportion (<5%) of false discoveries. Due to our very modest sample, we limited our analysis to cis-eQTLs. Although eQTLs at a larger distance undoubtedly exist, previous studies showed that beyond this distance, the effect size is on average much smaller, and the statistical power to detect them would be very low (Grundberg et al. 2012; Bryois et al. 2014 ). In-depth eQTL mapping procedures and replication strategies are further described (Appendix Methods).
Structured Association Analysis of OOMMSC-eQTLs
We employed a structured association approach to correct for population stratification bias. We genotyped 631 unrelated NSCL/P patients (39 of these were also analyzed in eQTL mapping) and 689 controls for 36 eQTL-SNPs and 122 ancestryinformative markers (AIMs), followed by quality control procedures (Appendix Methods). We used Structure Software v2.3.4 (Falush et al. 2003) to infer the genomic average of ancestry components for each individual and STRAT Software (Pritchard et al. 2000) to test association for 36 selected eQTLSNPs, conditioning on individual ancestry proportions. We adjusted association P values for these 36 independent tests (Bonferroni correction). The analyses parameters and parental populations data are described in the Appendix Methods.
Independent NSCL/P Case-Control Samples
The NSCL/P meta-analysis comprised 2 studies, in which genotypes were imputed using IMPUTE2 and 1000 Genome Project individuals as the reference panel (Ludwig et al. 2012 (Ludwig et al. , 2017 . One (meta_Euro) combined 666 European case-parent trios (including European Americans) with 399 cases and 1,318 controls of Central European origin. The second data set (meta_All) included 795 Asian case-parent trios (individuals from China, Taiwan, Singapore, Korea, and Philippines) in addition to meta_Euro samples.
The samples of 149 NSCL/P patients (128 cleft lip and palate and 21 cleft lip only) and 318 unaffected controls of Mayan descent were collected within the context of surgical outreach programs in Mexico (Rojas-Martinez et al. 2010) . Genotyping of rs1063588 and rs6546909 was performed using the KASP assay (LGC Genomics) on a LightCycler II (Roche). Association analysis was performed with the conventional χ 2 allelic association test (Clarke et al. 2011) .
Sanger Sequencing of MRPL53
We amplified coding and intronic regions of the MRPL53 gene using DNA samples from 203 NSCL/P individuals, with 189 of 203 overlapping the case-control sample (Appendix Table 7 ; PCR primers upon request). PCR products were Sanger sequenced by capillary electrophoresis in the ABI3730 DNA Analyzer (Applied Biosystems). Sequences were visualized in Sequencher 5.2 analysis software (Gene Codes). We compared NSCL/P allelic frequencies with those observed in our inhouse database of 609 control exomes from the CEGH-CEL repository (233/609 controls overlapping the case-control association sample) (Naslavsky et al. 2017) .
Results
Identification of cis-eQTLs in OOM Mesenchymal Stem Cells
First, we established OOMMSC primary cultures from OOM samples obtained from 42 NSCL/P-affected and 4 normal individuals subjected to reconstructive plastic surgery (Appendix Table 1 ). Second, we confirmed the mesenchymal immunophenotype of OOMMSCs (Appendix Table 2 ) and isolated DNA and RNA from cell cultures for genotyping and expression microarray analyses (Fig. 1) .
To identify genetic variants affecting gene expression in OOMMSCs, we correlated normalized gene expression with genotypes of all single-nucleotide polymorphisms (SNPs) flanking the TSS of each transcript, resulting in 3,897,692 SNPtranscript associations (i.e., total tests performed; Table 1 ).
Due to our limited sample size to map eQTLs, we explored the abundance of putative significant tests in our observed data by comparing it to 2 distinctly randomized P value distributions of n = 3,897,692 (n = total eQTLs tested). The underlying assumption is that P values of true-positive discoveries are close to 0, while P values of true null hypotheses have a uniform distribution between 0 and 1. Therefore, we first generated a random uniform distribution of P values ranging from 0 to 1 (expected). Second, by performing the same cis-association tests with TSS flanking SNPs but using shuffled expression values, we derived the empiric P values for the null hypothesis. By comparing observed over permuted or observed over expected distributions (Appendix Fig. 1 ), we detected an overall excess of low P values in our observed data set, indicating that despite our small sample size, we have sufficient power to detect eQTLs.
We selected the most significantly associated SNP of each transcript and then assessed the statistical significance of these top associations: 12 cis-eQTLs remained significant under 5% false discovery rate (FDR) (β-adjusted P < 1.08 × 10 -5 ; Table 1 and Appendix Table 3 ). All significant OOMMSC-eQTLs were located within ±100 kb of the TSS (absolute median SNP-TSS distance = 9,926 bp). We did not observe any functional annotation term significantly enriched among genes where an eQTL was identified (eQTL-genes). In addition, none of the 12 eQTL-genes identified here was previously recognized as influencing risk to NSCL/P.
Tissue Independency of OOMMSC-eQTLs
We employed 2 strategies (Grundberg et al. 2012 ) to test if OOMMSC-eQTLs could be replicated in independent cis-eQTL data sets of different tissues. First, we tested if OOMMSC candidate eQTLs (best-associated SNP per transcript, no FDR cutoff) were also identified as candidates in the GenotypeTissue Expression (GTEx) database, a public source of ciseQTLs identified in 44 human tissues from 449 individuals. We observed that the 250 top-significant OOMMSC candidate eQTLs were also among the candidates with low P values in GTEx data (Appendix Fig. 2 ) in 7 tissues: adipose-subcutaneous, brain-frontal cortex, cell Epstein-Barr virus (EBV)-transformed lymphocytes, cell-transformed fibroblasts, skeletal muscle, esophagus mucosa, and muscularis (n = 92-361 samples). Second, to replicate 9 of the aforementioned 12 significant eQTLs (after excluding 3 eQTLs due to undetectable transcript expression or inconsistent SNP or transcript identification in GTEx), we considered the same direction of allelic effect and the association significance (nominal P < 0.05) in 31 GTEx tissues. Replication rate of these 9 eQTLs was high, ranging from 0.78 (7/9; e.g., brain-hippocampus) to 1 (9/9; breastmammary, Appendix Table 4 ). Both replication analyses suggested a high tissue independency of the eQTLs identified in OOMMSC.
cis-eQTLs for MRPL53 Are Associated with NSCL/P
To test if OOMMSC-eQTLs were associated with risk of NSCL/P in a Brazilian case-control data set, we selected 36 cis-eQTL SNPs (Appendix Table 5 ) as either significant (FDR <5%) or borderline (FDR ≥5%, but nominal P < 0.05), located ±1 Mb from the TSS of genes involved in developmental pathways or orofacial cleft susceptibility (reviewed in Jugessur et al. 2009; He and Chen 2012; Parada and Chai 2012; Stanier and Pauws 2012) . Although the majority of the 36 eQTLs were not directly associated with those recognized candidate genes, our underlying hypothesis is that the genomic proximity might suggest regulatory site sharing (e.g., eQTLs with effects over the shared chromatin environment might indirectly affect neighbor genes).
The Brazilian cases and controls were admixed, and average proportions of European (EUR), African (AFR), and Native American (NAM) ancestries were, respectively, 58%, 21%, and 21% for patients and 69%, 17%, and 14% for controls (Appendix Fig. 3) . Using a structured association approach, in which ancestry proportions for each sample are considered covariates, we observed a significant association for rs1063588 (P = 0.0008; Table 2 and Appendix Table 5 ), which is an eQTL for MRPL53 (FDR <5%, mitochondrial ribosomal protein L53, located in 2p13). Given this result, we also tested the second cis-SNP most significantly associated with MRPL53, rs6546909 (nominal P = 8. 46 × 10 -6 , estimated slope = −0.81), and found a marginal but significant association between rs6546909 and risk of NSCL/P (P = 0.0036, Table 2 ). These eQTL-SNPs do not represent independent associations, as they are in high linkage disequilibrium (r 2 = 0.795, D′ = 0.952), and their respective minor alleles are equally low expressed (Fig. 2A) . The rs1063588 SNP is a missense variant (NM_001146158.1: c.397A>G; NP_001139630.1: p.Asp133Asn) located in exon 4 of MOGS and ~8.7 kb upstream from the MRPL53 TSS, while rs6546909 is a synonymous variant (NM133637.2: c.1842T>A) located in exon 11 of DQX1 and ~47 kb downstream from the MRPL53 TSS (Fig.  2B) . Functional effects of these variants on proteins are predicted as benign (Adzhubei et al. 2010) , and they were not significant eQTLs for these genes in OOMMSCs (nominal P > 0.23).
Evidence of a Population-Specific Effect
To check if a specific ancestry could be driving the association for rs1063588 and rs6546909, we grouped individuals into quartiles reflecting their overall AFR, NAM, or EUR ancestry estimated by structure ( Table 2 ). The highest association for rs1063588 was obtained among individuals with the highest NAM ancestry (Q 4-NAM ; NAM ancestry fractions ranging from 0.244 to 0.992; P = 0.006), while no association was seen in the quartiles with lower NAM ancestry (Q 1-3-NAM ; NAM ancestry fractions <0.244; P > 0.089). In addition, a trend for significant associations was found over quartiles with lower European and African ancestries, further reinforcing the suggestion that some NAM component might contribute to the observed association. In all groups, genotypes of controls followed HardyWeinberg expectations (P > 0.09). Using the Q 
Mutation Screening of MRPL53
We also investigated if other pathogenic mutations within this region could be implicated as influencing risk. We therefore screened MRPL53 coding regions in 203 NSCL/P individuals (Appendix Table 6 ) and identified 5 previously reported variants (rs1047911, rs141704877, rs78834087, rs148007344, and rs139817903) with minor allele frequencies (MAFs) of 0.38, 0.005, 0.012, 0.005, and 0.005, respectively, all of which were similar to control MAFs (Appendix Table 7 ). Comparable to our case-control sample, the average ancestry proportions were estimated as 58%, 22%, and 20% for MRLP53-screened patients and 75%, 17%, and 8% for controls, for EUR, NAM, and AFR components, respectively.
Rs1063588 and rs6546909 Association in Other Populations
Association statistics for rs1063588 and rs6546909 were analyzed in the imputed data in meta-analyses of both case-parent trios and case-control studies of NSCL/P in individuals of predominantly European ancestry (Ludwig et al. 2012 (Ludwig et al. , 2017 . In both meta_Euro (666 case-parent trios plus 399 cases and 1,318 controls of European origin) and meta_All (meta_Euro plus 795 Asian case-parent trios), SNPs rs1063588 and rs6546909 showed no evidence of association (P = 0.967 and P = 0.723 in meta_Euro and P = 0.732 and P = 0.738 in meta_ All, respectively, where Bonferroni-adjusted P values were used). Furthermore, local association tests including 1,598 SNPs located ±500 bp from rs1063588 (chr2:74190378− 75190378 genomic interval, GRCh37/hg19) yielded no evidence of any marginal association (Appendix Fig. 4) . No evidence of association was also observed in an independent sample of 149 NSCL/P cases and 318 controls of Mayan descent (Appendix Table 8 ).
Discussion
A common challenge when studying complex disorders is to understand the missing heritability and the molecular mechanisms underlying the GWAS signals of noncoding genetic variants. Here, we explored these issues through an approach that connects genetic variants with gene expression levels and a complex disease phenotype. Despite the small sample size for eQTL mapping (n = 46) and the use of mesenchymal stem cells mostly derived from affected individuals, we were able to identify regulatory genetic variants in OOMMSCs, which were in turn common to several other tissues. Indeed, in a low-powered analysis such as ours, it would be expected to reach genomic significance only for those eQTLs with high effect sizes, which are usually tissue independent (Grundberg et al. 2012) . Therefore, our results suggest that the use of mostly affected samples seems to not interfere in the identification of regulatory mechanisms common to multiple tissues.
Among the OOMMSC-eQTLs tested for association here, we identified a significant signal from a locus with 2 eQTLs for MRPL53 in high pairwise linkage disequilibrium (LD) (rs1063588 and rs6546909). Both SNPs display considerable variability in allele frequency across populations, and this fact may confound the interpretation of risk alleles in a context of admixed samples and population-specific risk effects. To evaluate if all ancestries contributed to the observed association and identify the respective risk alleles, we performed association tests with different thresholds of genomic ancestry in this highly admixed Brazilian sample. We found increasing significance for subjects with higher NAM ancestry, despite smaller sample sizes, while no significance was observed for groups with higher AFR and EUR ancestries, suggesting the association seen in the whole sample was mainly driven by alleles of NAM origin. Alleles rs1063588_G and rs6546909_A were correlated with high MRPL53 expression levels, and in the subset of highest NAM ancestry, their frequencies were higher in cases and could be considered NAM-specific risk alleles.
We were unable to replicate this association in a metaanalysis sample including European and Asian individuals (Beaty et al. 2010; Mangold et al. 2010; Ludwig et al. 2012 ). Therefore, it seems unlikely the differences in LD patterns across populations would be a major reason behind this lack of association in Europeans or Asians. In addition, no apparent significant signal at rs1063588 and rs6546909 was found in a sample of case-controls from Argentina, Guatemala, Colombia, Puerto Rico, and US Latinos (Leslie et al. 2016; E. Leslie personal communication 2016) . We also did not observe any association for these markers in the Mayan sample of NSCL/P cases and controls, which is not unexpected as they differ from other NAM populations from the north of Brazil (Homburger et al. 2015) . In addition, the remarkable contribution of the European component to the Latin American populations may dilute the risk effect.
We suggest the locus reported here may represent a populationspecific risk factor. Other population-specific loci have already been recently reported for NSCL/P, such as 15q22, which reached genome-wide significance in Europeans and Mexicans only but not in Asians (Ludwig et al. 2012 (Ludwig et al. , 2014 , and 16p13.3, significant only in the Chinese population (Sun et al. 2015) . In addition, stratification by ancestry groups recently revealed novel NSCL/P susceptibility loci among individuals with Central and South American ancestry (Leslie et al. 2016) . Our work, therefore, reinforces how such population-specific risk factors may represent an important contribution for NSCL/P heritability.
MRPL53 encodes a component of the large subunit of the mitochondrial ribosome (39S). A proper functioning of mitochondrial translation machinery is required for the mitochondrial oxidative phosphorylation system and is also crucial for cellular functions during development, such as cell growth, differentiation, and migration (Sylvester et al. 2004) . If these cellular functions are impaired, as shown for MRPL18, another member of this gene family (Zhang et al. 2015) , dysregulation of MRPL53 levels could disrupt craniofacial development.
A potential role for MRPL53 in controlling risk to NSCL/P is supported by findings from other studies. First, MRPL53 is highly expressed in embryonic structures like tongue, throat, trachea, and skeletal muscle (Petryszak et al. 2015) . Also, there is a weak signal of MRPL53 subcellular location in human and mouse nucleoli, suggesting this gene may play a role in nuclear ribosome biogenesis (Uhlen et al. 2010) . Finally, MRPL53 was detected among MYC-interacting proteins in cell lines derived from normal human fibroblasts (Agrawal et al. 2010) . It is noteworthy that MYC active enhancers during facial development are located near the strongest GWAS signals for NSCL/P (Uslu et al. 2014) . In an attempt to find supporting evidence for some role of MRPL53 in NSCL/P etiology, we sequenced this gene in 203 patients but did not detect any obvious pathogenic mutations. The sample's limited size and the lack of NAM ancestry in this follow-up study may explain these negative results, however.
In summary, for the first time, OOMMSC cis-eQTLs are described and provide a clue about a novel NSCL/P locus. Further studies are necessary to explore MRPL53 function, as well as the role SNPs rs1063588 and rs6546909 might play in regulatory functions during development, in addition to their roles in NSCL/P as a population-specific genetic risk factor. By documenting the functional consequences of genetic variants over the transcriptome of a cell type derived from a disease-related tissue, we have demonstrated a valuable approach to dissect the genetic architecture of a multifactorial disorder.
